Skip to main content
. 2016 Mar 16;31(1):134–141. doi: 10.3803/EnM.2016.31.1.134

Table 2. Relationship between Development of Diabetes and Clinical Parameters.

Variable Univariate analysis Model 1 Model 2
Age, yr 0.974 (0.941-1.009)
Female sex 1.467 (0.817-2.634)
Waist circumference, cm 1.055 (1.017-1.095) 1.093 (1.001-1.193) 1.046 (0.999-1.095)
BMI, kg/m2 1.114 (1.004-1.236) 0.812 (0.630-1.036)
SBP, mm Hg 1.041 (1.020-1.062) 0.995 (0.959-1.033)
DBP, mm Hg 1.101 (1.060-1.143) 1.104 (1.033-1.179) 1.096 (1.049-1.145)
Fasting glucose, mmol/L 1.106 (1.060-1.154) 1.114 (1.035-1.198) 1.104 (1.050-1.162)
Fasting insulin, pmol/L 1.014 (0.982-1.047)
Glucose, PP2, mmol/La 1.026 (1.010-1.042) 1.016 (0.996-1.036)
Insulin, PP2, pmol/La 1.005 (0.990-1.019)
Hemoglobin A1c, % 6.605 (2.842-15.347) 5.314 (1.870-15.098) 4.662 (1.789-12.145)
Total cholesterol, mmol/L 1.004 (0.994-1.014)
Triglyceride, mmol/L 1.004 (1.000-1.007) 1.002 (0.997-1.007)
LDL-C, mmol/L 1.001 (0.991-1.011)
HDL-C, mmol/L 0.972 (0.940-1.006)
Albumin, g/L 3.823 (0.631-23.182)
HOMA-B 0.999 (0.998-1.001)
HOMA-IR 1.095 (0.937-1.280)
Total GLP-1, pmol/L 0.936 (0.845-1.037) 0.954 (0.839-1.086) 0.941 (0.833-1.063)
Total GIP, pmol/L 1.004 (1.000-1.007) 1.003 (0.998-1.008) 1.005 (1.000-1.010)
Family history of DM, yes/no 5.874 (1.468-23.494) 2.110 (0.330-13.472)

Values are expressed as odds ratio (95% confidence interval).

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP2, postprandial 2 hours; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; HOMA-B, homeostasis model of assessment-β cell function; HOMA-IR, homeostasis model of assessment-insulin resistance; GLP-1, glucagon-like peptide-1; GIP, glucose-dependent insulinotropic peptide; DM, diabetes mellitus.

aAccording to the method section, it should be 2-hour plasma glucose during 75 g oral glucose tolerance test. Or, the authors should mention that they performed postprandial measures, too.